A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy

Trial Profile

A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2015

At a glance

  • Drugs Bupivacaine (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IMPROVE-open
  • Sponsors Pacira Pharmaceuticals
  • Most Recent Events

    • 07 May 2013 Trial status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 07 May 2013 Trial status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 07 May 2013 Trial status changed from recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top